Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTK cardioplegia effects on sodium, osmolarity, and acid-base balance
NL-OMON43165Active, not recruiting
- Sponsor
- Catharina Ziekenhuis
- Start
- Dec 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of HTK Custodiol and St Thomas' cardioplegia solution in cardiac disease (2 cohorts), sponsored by Catharina Ziekenhuis. Primary endpoints: Serum sodium concentration, Serum osmolarity and 1 more. Started Dec 2017; status: active, not recruiting.
02
Drugs
HTK CustodiolSt Thomas' cardioplegia solution
03
Conditions
cardiac disease
Beyond the preview
Go deeper on NL-OMON43165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43165.